Doctor profile · Federal record

Dr. Megan Followwell, PA-C

Physician Assistant · Tyler, TX

  • NPI 1053537274
  • Accepts Medicare
  • MIPS 98.6 / 100 · 2023
  • 20 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
5777 New Copeland RD
Tyler, TX 757033905
(903) 561-9255

Credentials & registration

NPPES · NUCC
NPI registered
April 2007 — 19 yrs on file
Profile last updated
October 18, 2023
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
363A00000X — NUCC code
State license (1)
Texas #PA05176

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1053537274. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
11,703
Distinct HCPCS
10
Medicare allowed
$432,197
HCPCS Description Services Patients Avg allowed
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 3,900 18 $42
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 3,120 30 $35
86235 Measurement of antibody for assessment of autoimmune disorder, any method 1,728 178 $17
99214 Established patient office or other outpatient visit, 30-39 minutes 714 460 $104
83516 Analysis of substance using immunoassay technique, multiple step method 420 176 $11
86225 Measurement of dna antibody, native or double stranded 216 178 $13
86226 Measurement of dna antibody, single stranded 216 178 $12
86200 Measurement of antibody for rheumatoid arthritis assessment 210 176 $13
86431 Rheumatoid factor level 210 176 $6
96413 Administration of chemotherapy into vein, 1 hour or less 145 56 $105

In context: peer comparison

Among 24 peers in Tyler Physician Assistant, average services per provider: 261. This provider delivers 45× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$885
Transactions
36
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 6 $179.00
Amgen INC. 8 $165.98
Novartis Pharmaceuticals Corporation 3 $85.20
Fresenius Kabi USA, LLC 4 $83.25
AstraZeneca Pharmaceuticals Lp 3 $77.45
Lilly USA, LLC 2 $51.75
Aurinia Pharma U.S., INC. 2 $40.95
Ucb, INC. 1 $31.65
Bioventus LLC 1 $23.13
Sobi, INC 1 $21.72
Boehringer Ingelheim Pharmaceuticals, INC. 1 $20.68
Sandoz INC. 1 $19.36
Kyowa Kirin, INC. 1 $19.08
GlaxoSmithKline, LLC. 1 $18.05
Pfizer INC. 1 $17.44

By nature of payment

Food and Beverage
$885

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
4,217
Patients
1,334
Total drug cost
$829,909
Drug Type Claims Patients Total cost
Prednisone Generic 1,173 417 $7,938
Tramadol Hcl Generic 471 153 $3,078
Duloxetine Hcl Generic 347 101 $9,645
Hydroxychloroquine Sulfate Generic 329 93 $23,753
Methotrexate (Methotrexate Sodium) Brand 323 104 $9,016
Gabapentin Generic 280 85 $3,581
Celecoxib Generic 248 66 $9,974
Sulfasalazine Generic 172 61 $3,046
Allopurinol Generic 153 53 $1,865
Meloxicam Generic 152 52 $1,021

Frequently asked questions

Auto-generated from federal data
What is Dr. Megan Followwell's medical specialty?
Dr. Megan Followwell practices Physician Assistant in Tyler, TX.
Where does Dr. Megan Followwell practice?
Dr. Megan Followwell practices at 5777 New Copeland RD, Tyler, TX 757033905. Office phone: 9035619255.
What is Dr. Megan Followwell's NPI?
Dr. Megan Followwell's National Provider Identifier (NPI) is 1053537274, issued by NPPES.
Does Dr. Megan Followwell accept Medicare assignment?
Yes. Dr. Megan Followwell accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Megan Followwell commonly perform?
Top Medicare-reported procedures in 2023: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab-abda, biosimilar, (renflexis), 10 mg (HCPCS Q5104); Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS 86235). Source: CMS Medicare Physician & Other Practitioners file.